The Global Health Body Raises Alert Over Severe Lack of Weight-Loss Injections
Under 10% of patients who could benefit from weight-loss injections such as Wegovy have access to them, caution the global health agency as it issues its initial advice on the therapies.
Given in excess of 1,000,000,000 individuals worldwide currently classified as obese, it is urging increased and just availability to GLP-1 medication.
According to estimates, more than two billion could be obese by 2030 without intervention.
"Our new guidelines recognises that obesity is a lifelong illness that can be addressed with thorough and continuous support," remarked its chief Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and supply-chain constraints are major hurdles to widespread availability to the treatments that can aid individuals in losing significant weight, explains the body.
Skinny Jab Scarcity
Even under the current most favorable scenario, the production of GLP-1 therapies might only reach approximately 100 million people – fewer than 10% of those who need them, according to the WHO.
The recommendation urges countries and companies to expand access, via measures like patent sharing.
Exclusive production rights on a key compound – the core ingredient of a leading brand – is due to expire in a number of nations in 2026.
The Way Obesity Drugs Operate
The injections imitate a body's own hormone to delay gastric emptying, curb appetite and increase the sense of being full so people consume fewer calories.
Individuals typically start to lose weight after several weeks of starting on the regular doses.
Evidence suggests patients may regain a significant portion within a year of halting the treatment, when their normal food cravings come back.
Being above a healthy weight elevates your chance for contracting medical conditions, including type 2 diabetes, heart disease, brain attack, and specific malignancies.
Excess weight impacts individuals in all nations and was responsible for millions of deaths worldwide in 2024, per the WHO.
